v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 25, 2020
Sep. 27, 2019
OPERATING ACTIVITIES    
CONSOLIDATED NET INCOME $ 6,294 $ 6,920
Depreciation and amortization 1,106 965
Stock-based compensation expense 88 146
Deferred income taxes 10 (326)
Equity (income) loss - net of dividends (565) (336)
Foreign currency adjustments (145) 79
Significant (gains) losses on sales of assets - net (899) (389)
Other Operating Activities, Cash Flow Statement 671 147
Other items 562 444
Net change in operating assets and liabilities (902) 121
Net Cash Provided by (Used in) Operating Activities 6,220 7,771
INVESTING ACTIVITIES    
Purchases of investments (12,051) (4,113)
Proceeds from disposals of investments 6,482 5,674
Acquisitions of businesses, equity method investments and nonmarketable securities (989) (5,376)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 46 266
Purchases of property, plant and equipment (759) (1,206)
Proceeds from disposals of property, plant and equipment 156 944
Other investing activities 43 (90)
Net Cash Provided by (Used in) Investing Activities (7,072) (3,901)
FINANCING ACTIVITIES    
Issuances of debt 26,898 19,598
Payments of debt (17,977) (21,716)
Issuances of stock 514 923
Purchases of stock for treasury (93) (690)
Payments of Dividends (3,522) (3,419)
Other financing activities 153 (33)
Net Cash Provided by (Used in) Financing Activities 5,973 (5,337)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS (36) (75)
CASH AND CASH EQUIVALENTS    
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents during the period 5,085 (1,542)
Balance at beginning of period 6,737 9,318
Balance at end of period 11,822 7,776
Less: Restricted Cash and Restricted Cash Equivalents at end of period 437 245
Cash and cash equivalents $ 11,385 $ 7,531

Source